PODD
Insulet CorporationNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$15.87B
P/E Ratio
65.36
EPS
$3.45
Beta
1.44
52W High
$354.88
52W Low
$216.49
50-Day MA
$253.15
200-Day MA
$297.10
Dividend Yield
—
Profit Margin
9.12%
Forward P/E
36.23
PEG Ratio
1.58
About Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.
Fundamentals
| Revenue (TTM) | $2.71B |
| Gross Profit (TTM) | $1.94B |
| EBITDA | $564.20M |
| Operating Margin | 18.70% |
| Return on Equity | 18.10% |
| Return on Assets | 9.43% |
| Revenue/Share (TTM) | $38.50 |
| Book Value | $21.53 |
| Price-to-Book | 10.55 |
| Price-to-Sales (TTM) | 5.86 |
| EV/Revenue | 5.99 |
| EV/EBITDA | 33.15 |
| Quarterly Earnings Growth (YoY) | 3.90% |
| Quarterly Revenue Growth (YoY) | 31.20% |
| Shares Outstanding | $70.40M |
| Float | $70.11M |
| % Insiders | 0.33% |
| % Institutions | 103.03% |
Historical Volatility
HV 10-Day
41.61%
HV 20-Day
31.99%
HV 30-Day
37.34%
HV 60-Day
32.08%
HV Rank
59.9%
Volatility is currently expanding
Analyst Ratings
Consensus ($353.46 target)
6
Strong Buy18
Buy1
Hold1
Strong SellData last updated: 3/25/2026